Skip to main content
. 2023 May 26;108(11):e1424–e1432. doi: 10.1210/clinem/dgad289

Table 2.

PubMed search facets

Ref Facet Search terms
1 Chronic kidney disease (“chronic kidney disease” OR CKD OR “kidney failure” OR “renal outcome” OR “renal outcomes” OR “renal failure”):[tiab]
2 Biomarkers or outcomes (“secondary hyperparathyroidism” OR SHPT
OR
calcium OR phosphorus
OR
“vitamin D” OR “25(OH)D” OR “1,25(OH)”
OR
pth OR “parathyroid hormone” OR ipth OR parathormone OR
FGF-23 OR FGF23 OR “fibroblast growth factor 23”
OR
BSAP OR P1NP OR CTX OR hepcidin OR “TRAP 5b” OR “calcification propensity”
OR
proteinuria
OR
hypercalcaemia OR hypercalcemia OR hyperphosphatemia
OR
progression
OR
CVD OR “cardiovascular disease” OR “cv event” OR “cardiovascular event” OR “cardiovascular events”
OR
mortality OR death
OR
fracture OR fractures OR fx
OR
hospitalization OR hospitalisation
OR
anemia OR anaemia
OR
parathyroidectomy OR ptx
OR
“bone mineral density” OR “bone turnover” OR “bone metabolic” OR BMD OR “bone disease” OR MBD OR “CKD-MBD”):[tiab]
3 Treatments (calcitriol OR paricalcitol OR alfacalcidol OR alphacalcidol OR 1-hydroxycholecalciferol OR doxercalciferol OR “vitamin D receptor agonist” OR “vitamin D receptor activator” OR “vitamin D receptor activation” OR VDRA OR VDRAs OR calcifediol OR calcidiol OR NVD OR “nutritional vitamin D” OR cholecalciferol OR ergocalciferol OR calcimimetic OR cinacalcet):[tiab]
4 Language English[lang]
5 Publication type NOT (review OR comment OR meta-analysis)
6 Effect of drug therapy on biomarker levels or outcomes in CKD #1 AND #2 AND #3 AND #4 NOT #5